Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Published in: European Journal of Nuclear Medicine and Molecular Imaging 4/2006

01-04-2006 | Image of the month

The possible role of 68Ga-DOTATATE PET in malignant abdominal paraganglioma

Authors: Zarni Win, Lucy Rahman, Joy Murrell, Jeannie Todd, Adil Al-Nahhas

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 4/2006

Login to get access

Excerpt

Paragangliomas are rare tumours that arise within the sympathetic nervous system originating from the neural crest. Nearly 90% of these tumours originate in the medulla of the adrenal glands, and are known as phaeochromocytomas. The remaining 10% are extra-adrenal and are termed paragangliomas. In all, 10% are malignant, and these are often difficult to manage. …
Literature
1.
Ell PJ, Gambhir SS. Nuclear medicine in clinical diagnoses and treatment. 3rd ed. New York: Churchill Livingstone; 2004
2.
Hofmann M, Maecke H, Borner R, Weckesser E, Schoffski P, Oei L, et al. Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data. Eur J Nucl Med 2001;28:1751–7PubMedCrossRef
3.
Kowalski J, Henze M, Schuhmacher J, Macke HR, Hofmann M, Haberkorn U. Evaluation of positron emission tomography imaging using [68Ga]-DOTA-DPhe1-Tyr3-octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors. Mol Imaging Biol 2003;5:42–8PubMedCrossRef
4.
Lewington V. Targeted radionuclide therapy for neuroendocrine tumours. Endocr Relat Cancer 2003;10(4):497–501PubMedCrossRef
Metadata
Title
The possible role of 68Ga-DOTATATE PET in malignant abdominal paraganglioma
Authors
Zarni Win
Lucy Rahman
Joy Murrell
Jeannie Todd
Adil Al-Nahhas
Publication date
01-04-2006
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 4/2006
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-005-0035-9

Other articles of this Issue 4/2006

European Journal of Nuclear Medicine and Molecular Imaging 4/2006 Go to the issue

Short communication

Uptake of bone-seekers is solely associated with mineralisation! A study with 99mTc-MDP, 153Sm-EDTMP and 18F-fluoride on osteoblasts

Original article

Evaluation of the pharmacokinetics of 68Ga-DOTATOC in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy

Image of the month

PET/MRI depicts the exact location of meniscal tear associated with synovitis

Original article

Synthesis of 99mTc-HYNIC-interleukin-12, a new specific radiopharmaceutical for imaging T lymphocytes

Molecular imaging

Multi-tracer small animal PET imaging of the tumour response to the novel pan-Erb-B inhibitor CI-1033

Original article

Long-term assessment of striatal dopamine transporters in parkinsonian patients with intrastriatal embryonic mesencephalic grafts